검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | oxycodone hydrochloride (oxycodone hydrochloride) Ensysce Biosciences·Brain and Central Nervous System T… ORR 13.7% |
|---|---|
Overview Program | oxycodone hydrochloride |
Overview Company | Ensysce Biosciences |
Overview Modality | CGT |
Overview Target | Brain and Central Nervous System Tumors |
Overview Indication | Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders |
Overview Phase | PRECLINICAL |
Overview Status | DISCONTINUED |
PK/PD Species | Rat, Human |
PK/PD Animal (cat.) | Human, Rat |
PK/PD Experiment | Pharmacokinetic |
Toxicology Species | Rat, Human |
Toxicology Animal (cat.) | Human, Rat |
Toxicology Major finding | Comparison of oxycodone hydrochloride injection versus sufentanil for postoperative analgesia in patients undergoing minimally invasive cardiac valve replacement: study protocol for a single-centre, randomised, double-blind non-inferiority trial.. With the advancement of the ERAS (Enhanced Recovery After Surgery) concept, minimally invasive heart valve replacement surgery has become widely perform… |
Clinical Primary efficacy | ORR 13.7% |
Clinical ORR | 13.7% |
Clinical Result source | ClinicalTrials.gov NCT00386243 |
Clinical Data Tier / Score | A · 8 |
Clinical Program phase | PRECLINICAL |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | oxycodone hydrochloride (oxycodone hydrochloride) Ensysce Biosciences·Brain and Central Nervous System T… ORR 13.7% |
|---|---|
Overview Program | oxycodone hydrochloride |
Overview Company | Ensysce Biosciences |
Overview Modality | CGT |
Overview Target | Brain and Central Nervous System Tumors |
Overview Indication | Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders |
Overview Phase | PRECLINICAL |
Overview Status | DISCONTINUED |
PK/PD Species | Rat, Human |
PK/PD Animal (cat.) | Human, Rat |
PK/PD Experiment | Pharmacokinetic |
Toxicology Species | Rat, Human |
Toxicology Animal (cat.) | Human, Rat |
Toxicology Major finding | Comparison of oxycodone hydrochloride injection versus sufentanil for postoperative analgesia in patients undergoing minimally invasive cardiac valve replacement: study protocol for a single-centre, randomised, double-blind non-inferiority trial.. With the advancement of the ERAS (Enhanced Recovery After Surgery) concept, minimally invasive heart valve replacement surgery has become widely perform… |
Clinical Primary efficacy | ORR 13.7% |
Clinical ORR | 13.7% |
Clinical Result source | ClinicalTrials.gov NCT00386243 |
Clinical Data Tier / Score | A · 8 |
Clinical Program phase | PRECLINICAL |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
추천 비교
추천 비교